Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.
NCT02048787
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
Buparlisib
Sponsor
Novartis Pharmaceuticals